Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for epidermal growth factor receptor variant III and their uses

Antibodies specific for epidermal growth factor receptor variant III and their uses

US Patent 11279764 · Granted Mar 22, 2022

Estimated economic value: $2,188,468,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Chimeric antigen receptors targeting FLT32025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Methods of manufacturing allogeneic CAR T cells2024
Chimeric antigen receptors targeting CD702024
Constitutively active chimeric cytokine receptors2024
BCMA CAR-T cells with enhanced activities2024
Antibodies specific for CD70 and their uses2024
Chimeric antigen receptors targeting B-cell maturation antigen2024
Polynucleotides encoding rituximab-resistant chimeric antigen receptors2024
Chimeric cytokine receptors bearing a PD-1 ectodomain2023